首页 | 本学科首页   官方微博 | 高级检索  
     


Application of the Movement Disorder Society prodromal criteria in healthy G2019S‐LRRK2 carriers
Authors:Anat Mirelman PhD  Rachel Saunders‐Pullman MD  MS   MPH  Roy N. Alcalay MD  MSc  Shiran Shustak BSc  Avner Thaler MD  PhD  Tanya Gurevich MD  Deborah Raymond MS  Helen Mejia‐Santana MS  Martha Orbe Reilly MD  Laurie Ozelius PhD  Lorraine Clark PhD  Mali Gana‐Weisz PhD  Anat Bar‐Shira PhD  Avi Orr‐Utreger MD  PhD  Susan B. Bressman MD  Karen Marder MD  MPH  Nir Giladi MD  the AJ LRRK Consortium
Affiliation:1. Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel‐Aviv, Israel;2. Sackler School of Medicine, Sagol School for Neuroscience, Tel Aviv University, Tel‐Aviv, Israel;3. Departments of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA;4. Icahn School of Medicine at Mount Sinai, New York, New York, USA;5. Department of Neurology, College of Physicians and Surgeons, Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA;6. Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA;7. Genetics Institute, Tel Aviv Medical Center, Tel Aviv, Israel
Abstract:
Keywords:LRRK2  Parkinson's disease  prodromal  MDS prodromal criteria
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号